Morbidity and mortality of colorectal cancer (CRC) is high in the Western world. 1 Early
detection by screening programs may reduce this burden significantly, but only if the …

Colorectal cancer is a leading cause of cancer death throughout the world. There is
evidence that screening of average-risk individuals can result in mortality reduction with …

Aim Insufficient adherence to colorectal cancer (CRC) screening impedes individual and
population health benefits, with about one-third of individuals non-adherent to available …

Objectives: Fecal blood testing is a noninvasive alternative to colonoscopy for colorectal
cancer (CRC) screening and is preferred by a substantial proportion of individuals …

Objectives: To describe adherence with United States Preventive Services Task Force
(USPSTF) colorectal cancer (CRC) screening recommendations over a 10-year period in a …

Importance Mailed fecal immunochemical test (FIT) outreach is more effective than
colonoscopy outreach for increasing 1-time colorectal cancer (CRC) screening, but long …

Background The effectiveness of colorectal cancer screening programs based on the fecal
immunochemical test (FIT) is influenced by program adherence during consecutive …

Aims While most guidelines still recommend colorectal cancer (CRC) screening initiation at
age 50 years in average-risk individuals, guideline-creating bodies are starting to lower the …

This document is a focused update to the 2017 colorectal cancer (CRC) screening
recommendations from the US Multi-Society Task Force on Colorectal Cancer, which …

Introduction Fecal immunochemical testing (FIT) is an attractive approach for colorectal
cancer screening at community health centers. This budget impact analysis investigated …